Patents by Inventor Colin ORFORD

Colin ORFORD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
    Patent number: 11129810
    Abstract: This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: September 28, 2021
    Assignee: MEREO BIOPHARMA 1 LIMITED
    Inventors: Colin Orford, Cyril Clarke, Colm Farrell, Jacqueline Parkin, Stefan De Buck
  • DOSAGE REGIMEN FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Publication number: 20200281896
    Abstract: This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
    Type: Application
    Filed: February 18, 2020
    Publication date: September 10, 2020
    Applicant: MEREO BIOPHARMA 1 LIMITED
    Inventors: Colin ORFORD, Cyril CLARKE, Colm FARRELL, Jacqueline PARKIN, Stefan DE BUCK
  • Dosage regimen for the treatment of acute exacerbations of inflammatory conditions
    Patent number: 10617674
    Abstract: This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of inflammatory conditions.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: April 14, 2020
    Assignee: MEREO BIOPHARMA 1 LIMITED
    Inventors: Colin Orford, Cyril Clarke, Colm Farrell, Jacqueline Parkin, Stefan De Buck
  • Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
    Patent number: 10603306
    Abstract: This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: March 31, 2020
    Assignee: MEREO BIOPHARMA 1 LIMITED
    Inventors: Colin Orford, Cyril Clarke, Colm Farrell, Jacqueline Parkin, Stefan De Buck
  • DOSAGE REGIMEN FOR THE TREATMENT OF ACUTE EXACERBATIONS OF INFLAMMATORY CONDITIONS
    Publication number: 20190091203
    Abstract: This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of inflammatory conditions.
    Type: Application
    Filed: March 8, 2016
    Publication date: March 28, 2019
    Applicant: MEREO BIOPHARMA 1 LIMITED
    Inventors: Colin ORFORD, Cyril CLARKE, Colm FARRELL, Jacqueline PARKIN, Stefan DE BUCK
  • DOSAGE REGIMEN FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Publication number: 20190060279
    Abstract: This invention relates to a novel dosage regimen for administration of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof, namely in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
    Type: Application
    Filed: March 8, 2016
    Publication date: February 28, 2019
    Applicant: MEREO BIOPHARMA 1 LIMITED
    Inventors: Colin ORFORD, Cyril CLARKE, Colm FARRELL, Jacqueline PARKIN, Stefan DE BUCK